Sickle Cell Genomics

About the Priority Setting Partnership

Sickle cell is a disorder of the haemoglobin in the red blood cells. There are an estimated 18,000 people with the disease in the UK and 3 million globally.

Genomics England and the Sickle Cell Society will work with patients, carers, carriers and healthcare professionals to identify uncertainties about the relationship between sickle cell and genomics.

For example: 

• how sickle cell progresses in individuals
• new treatment developments and links between severity and risk
• understanding the uncertainties in the practices used in this field of research

The initial survey opened in December 2024.